CDKN2B and hepatocellular carcinoma: In another in vitro study, hepatocellular carcinoma cells exhibited weaker viability, invasive and migratory activities, and stronger apoptotic activity after silencing ARlncRNA CDKN2B-AS1 and up-regulating miR-199a-5p.65